Crude Glycerine Oversupply Cycles in 2026: Myth or Market Reality?

Crude glycerine oversupply in 2026 is not a myth. Biodiesel expansion across Indonesia, Brazil, and the EU continues to push crude glycerine volumes into a market where downstream refining capacity and end-use demand cannot absorb them at pace. Scientific estimates placed potential crude glycerine supply at approximately 6.33 million tonnes against demand of around 4 million tonnes as early as 2025, with the structural gap likely widening in 2026 as Indonesia holds its B40 mandate and HVO scale-up removes future FAME-linked glycerine volumes. Buyers treating crude glycerine as a simple commodity play are missing the grade-level splits that make parts of this market genuinely tight, even as the headline surplus grows.

Crude Glycerine Supply Risk Profile 2026

Structural Oversupply Risk: HIGH

The core problem with crude glycerine is that its supply is not controlled by the glycerine market. It is controlled by the biodiesel market, and glycerine buyers have no seat at the table.

When biodiesel plants run at higher utilisation rates, more crude glycerine enters the market whether downstream buyers want it or not. When blending mandates are raised, as Indonesia did moving from B35 to B40 in 2025, the incremental biodiesel volumes bring incremental glycerine volumes with them. The market has no mechanism to produce less glycerine while producing more biodiesel.

The quantitative picture is stark. One peer-reviewed analysis estimated that potential crude glycerine supply could reach approximately 6.33 million tonnes by 2025, against demand of roughly 4 million tonnes. Within that 6.33 million tonne figure, approximately 680,000 tonnes are classified as highly impure material, which is effectively unsellable into standard industrial channels at any commercially meaningful price. The broader 2-million-tonne excess reflects a market where, even assuming full uptake by food, pharmaceutical, and personal care buyers, meaningful volumes remain stranded at biodiesel producers who lack refining infrastructure.

This is the structural risk that buyers underestimate most. The headline market size figures from research providers — often citing USD 3–4 billion in total glycerine market value and growth CAGRs of 4–5% — apply to the refined glycerine market. The crude glycerine market, specifically the 80–88% purity fraction that biodiesel plants generate as a direct output, is a different product with a different supply equation. Conflating the two leads buyers to misjudge their purchasing position.

The OECD-FAO Agricultural Outlook 2025-2034 projects biomass-based diesel production growing at a 1.68% annual rate, which compounds the structural surplus at the crude end of the market with each passing year that refining investment does not keep pace.

Policy Reversal Risk: MEDIUM — Indonesia B50 Shelved, But B40 Baseline Holds

Indonesia's decision to shelve its B50 mandate in January 2026, confirmed by Deputy Minister for Energy and Mineral Resources Yuliot Tanjung, reduces the most acute near-term supply spike risk. A B50 rollout would have driven domestic CPO demand up by an estimated 3 million tonnes, generating a proportional increase in crude glycerine output. The cancellation removed that volume from 2026 glycerine supply projections.

However, the B40 mandate — operational since early 2025 — remains firmly in place. Indonesia has allocated 15.6 million kiloliters of biodiesel for 2026 under the B40 framework. The government's stated rationale for holding at B40, rather than advancing to B50, centres on technical limitations in railways and heavy equipment, as well as Balikpapan refinery capacity, not on any reassessment of the biodiesel program itself. B50 trials continue.

For buyers, the practical implication is that Indonesia's crude glycerine output in 2026 will not deliver the step-change increase that B50 would have triggered, but it will continue generating volumes that flow primarily to China (accounting for approximately 66% of Indonesian glycerine exports in 2022, a share that has grown since) and to European refiners.

The geopolitical overlay matters. US tariffs on Indonesian palm oil at 19% and on Malaysian palm oil at 25% (effective from August 2025) create a cost disadvantage for Southeast Asian producers supplying US-bound customers, and may redirect some glycerine flows toward other markets, adding further pressure on European and Chinese import prices.

Concentration Risk: HIGH — Indonesia Dominates Export Flows

Indonesia has become the single largest glycerine exporter globally, overtaking Malaysia and the major European producers — Germany, the Netherlands, and Belgium — between 2015 and 2025. Indonesian shipments rose from approximately 195,000 tonnes in 2015 to an estimated 1 million-plus tonnes in 2025. This fivefold expansion reshapes counterparty risk for any buyer not tracking Indonesian supply-side variables.

The market structure that matters for crude glycerine buyers is as follows. Indonesia and Malaysia dominate export supply. China remains the largest single import market for crude glycerine, with import dependency estimated at approximately 82.5% in 2022 and rising since. Europe is the largest crude glycerine import region globally, with Europe and Southeast Asia together accounting for more than 55% of global crude glycerine demand.

This creates a bottleneck: if Indonesian plant utilisation rates fall — whether from CPO price spikes making biodiesel economics unfeasible, from weather-related disruptions to palm oil harvests, or from government subsidy recalibrations — European and Chinese buyers face simultaneous supply shortfalls with limited alternative origins ready to step in at comparable volumes and price levels.

The 2026 palm oil supply picture adds nuance here. Industry projections circulating through 2025 flagged the risk of Indonesia approaching a palm oil supply deficit by 2026 if B50 had proceeded — a risk that has been deferred, not eliminated, by the mandate delay. CPO output in 2024 was already estimated at 48.26 million tonnes, down 1.81 million tonnes year-on-year, and palm yield remains exposed to La Niña rainfall patterns and El Niño drought cycles.

Structural Risk: The HVO Counterforce — MEDIUM and Growing

The HVO expansion is the most underappreciated long-term structural risk in the crude glycerine supply equation, and it cuts in the opposite direction from everything else discussed here.

HVO (hydrotreated vegetable oil) produces renewable diesel through a hydrotreatment process that does not generate glycerine as a co-product. FAME biodiesel (fatty acid methyl ester), the conventional transesterification process that creates glycerine at approximately 10% by weight of biodiesel output, is being displaced by HVO in markets where infrastructure and policy support it. The global HVO market was valued at approximately USD 18.12 billion in 2025 and is projected to reach USD 20.44 billion in 2026, growing at a 12.8% CAGR.

Each percentage point of renewable diesel demand that shifts from FAME biodiesel to HVO removes a proportional volume of crude glycerine from future supply projections. This does not create a tightness problem in 2026, given the current structural surplus at the crude grade, but it creates a meaningful medium-term supply constraint for the refined-grade market.

Buyers of USP-grade and pharmaceutical-grade glycerine, who cannot use crude glycerine directly and depend on a dedicated refining step, are exposed to a world where the structural crude glycerine surplus does not translate into abundant refined supply if HVO continues gaining share and fewer FAME-linked glycerine refinery investments are made.

The FDA's 2023 requirement to test every excipient batch for diethylene and ethylene glycol contamination compounds this dynamic. Pharmaceutical-grade glycerine buyers now require 99.5%-plus purity produced under GMP conditions, concentrating procurement among a smaller pool of certified refiners. When the crude-to-refined margin spread reached USD 400–700 per tonne in 2024–2025, the incentive structure for new refining investment improved, but capex decisions respond to multi-year economics, not single-season spreads.

Recent Disruptions and Market Signals: Last 12 Months

Indonesia B40 Ramp-Up (Q1 2025): Indonesia's implementation of the B40 mandate created tight supply conditions in Indonesian domestic glycerine markets during Q1 2025, with prices rising from January through March. The initial January dip caused by oversupply quickly reversed as industrial activity picked up and CPO prices increased. B40 tightened the CPO feedstock balance, which raised glycerine production costs and temporarily offset the supply increase.

US Crude Glycerine Price Collapse (February–May 2025): US export prices for crude glycerine peaked at approximately USD 806 per tonne in February 2025 before falling to approximately USD 550 per tonne by May 2025 — a 32% decline in three months. US domestic production fell 2.3% to 541,000 tonnes in 2024 for the second consecutive annual decline, reflecting feedstock economics and plant configuration shifts, even as biodiesel demand rose.

European and Chinese Price Divergence (H2 2025): While US prices softened, European glycerol prices rose approximately 28% year-on-year in October 2025. Chinese import prices for glycerine rose approximately 50% over the same twelve-month period. This divergence reflects regional demand dynamics and the role of Indonesian supply in directing exports toward the highest-value destination at any given time.

US Tariffs on Southeast Asian Palm Oil (August 2025): Tariffs of 19% on Indonesian palm oil imports and 25% on Malaysian palm oil imports, effective August 2025, altered the economics of Southeast Asian glycerine reaching US buyers and contributed to redirecting some export flows toward European and Asian markets.

India Biodiesel Output Jump (2024–2025): India's biodiesel production jumped approximately 60% between 2024 and 2025, driven by used-cooking-oil and palm-stearin feedstock diversification. India's plant utilisation reached only 59.8%, indicating that feedstock access, not reactor capacity, remains the binding constraint. If India resolves feedstock access — through UCO collection infrastructure — India's incremental glycerine output could become material for regional buyers in Asia.

Conclusion

The crude glycerine oversupply cycle in 2026 is real, but it is not uniform across grades, geographies, or time horizons. The structural surplus at the impure crude end of the market is a genuine and growing problem for biodiesel producers without refining infrastructure. For refined-grade buyers, however, the same market contains a developing tightness narrative driven by HVO's displacement of FAME and by rising purity standards in pharmaceutical applications. The buyers most at risk in 2026 are those making procurement decisions based on the headline oversupply story without distinguishing which grade, which origin, and which policy variable actually governs their supply position.

For crude glycerine buyers seeking to navigate this split market, establishing clear grade specifications, diversifying origins, and building term contract coverage before Indonesian policy signals shift again are the three actions that reduce exposure the most.

Frequently Asked Questions

Q: Is the crude glycerine market actually oversupplied in 2026?
A: At the crude, impure-grade level (below 88% purity), yes. Scientific estimates have placed potential crude glycerine supply at approximately 6.33 million tonnes against effective demand of around 4 million tonnes, with a portion of the surplus effectively stranded as a low-value waste stream. Refined-grade markets are tighter, because HVO scale-up reduces future FAME biodiesel volumes and limits glycerine co-product generation in several key markets.

Q: What are the largest sources of crude glycerine supply globally?
A: Indonesia is the world's leading crude glycerine exporter, with shipments estimated above 1 million tonnes in 2025, followed by Malaysia, Brazil, and European biodiesel producers (primarily Germany, the Netherlands, and Belgium). Biodiesel production contributes approximately 60% of global glycerine supply, with the remainder from fatty acid and fatty alcohol manufacturing.

Q: How does HVO affect crude glycerine supply?
A: HVO (hydrotreated vegetable oil) produces renewable diesel without generating glycerine as a co-product, unlike conventional FAME biodiesel. As HVO gains market share in Europe and North America, each unit of biodiesel demand that shifts to HVO removes a proportional volume of crude glycerine from future supply. This creates a long-term supply constraint for refined-grade buyers even as the near-term crude-grade surplus continues.

Q: What happened to Indonesia's B50 biodiesel mandate in 2026?
A: Indonesia shelved its B50 mandate in January 2026, citing technical limitations for trains and heavy equipment and Balikpapan refinery capacity constraints. The country remains at B40, which became operative in early 2025. B50 trials continue, and a future rollout cannot be ruled out for 2027 or beyond.

Q: How should buyers respond to crude glycerine oversupply risk?
A: Buyers should distinguish their grade requirements before acting on the oversupply narrative — the surplus does not apply equally to all grades. For industrial crude-grade buyers, the current price environment favours forward purchasing and buffer stock building. For pharmaceutical and food-grade buyers, term contracts with GMP-certified refiners reduce qualification and availability risk as compliant supply becomes more concentrated among fewer certified producers.